A.P. PHARMA, INC.

Company

HERON THERAPEUTICS, INC. /DE/

Filed

June 22, 2007

Accession Number

0000902664-07-002075

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →